Guidance for Industry: Providing Regulatory Submissions to CBER in Electronic Format -- Investigational New Drug Applications (INDs) (PDF)
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 1, 2002
December 1, 2018
8570d177-c5f6-48b3-9e31-b55fcf3ec212
Related Documents
Content and Format of Chemistry, Manufacturing and Controls Information and Establishment Description Information for a Biological In Vitro Diagnostic Product: Guidance for Industry
Guidance DocumentMarch 8, 1999Center for Biologics Evaluation and Research
Providing Regulatory Submissions to the Center for Biologics Evaluation and Research (CBER) in Electronic Format - Biologics Marketing Applications: Guidance for Industry
Guidance DocumentNovember 1, 1999Center for Biologics Evaluation and Research
Efficacy Studies to Support Marketing of Fibrin Sealant Products Manufactured for Commercial Use: Guidance for Industry
Guidance DocumentMay 20, 1999Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.